New Zealand markets close in 3 hours 54 minutes

Takeda Pharmaceutical Company Limited (TAK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
14.84-0.07 (-0.47%)
At close: 04:00PM EDT
14.50 -0.34 (-2.29%)
After hours: 06:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 45.29B
Enterprise value 72.44B
Trailing P/E 25.82
Forward P/E 10.46
PEG ratio (5-yr expected) 0.53
Price/sales (ttm)1.66
Price/book (mrq)1.03
Enterprise value/revenue 0.02
Enterprise value/EBITDA 0.07

Trading information

Stock price history

Beta (5Y monthly) 0.90
52-week change 3-13.62%
S&P500 52-week change 3-5.29%
52-week high 317.43
52-week low 313.17
50-day moving average 314.65
200-day moving average 314.84

Share statistics

Avg vol (3-month) 32.58M
Avg vol (10-day) 32.91M
Shares outstanding 53.11B
Implied shares outstanding 6N/A
Float 83.06B
% held by insiders 10.01%
% held by institutions 11.89%
Shares short (12 May 2022) 45.3M
Short ratio (12 May 2022) 42.21
Short % of float (12 May 2022) 4N/A
Short % of shares outstanding (12 May 2022) 40.17%
Shares short (prior month 13 Apr 2022) 45.91M

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 45.39%
Trailing annual dividend rate 3180.00
Trailing annual dividend yield 31,207.24%
5-year average dividend yield 44.37
Payout ratio 460.92%
Dividend date 314 Dec 2009
Ex-dividend date 428 Sept 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 30 Mar 2022
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 6.45%
Operating margin (ttm)24.34%

Management effectiveness

Return on assets (ttm)4.16%
Return on equity (ttm)4.24%

Income statement

Revenue (ttm)3.57T
Revenue per share (ttm)1,141.35
Quarterly revenue growth (yoy)13.40%
Gross profit (ttm)2.46T
EBITDA 1.45T
Net income avi to common (ttm)230.06B
Diluted EPS (ttm)0.57
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)849.7B
Total cash per share (mrq)274.03
Total debt (mrq)4.35T
Total debt/equity (mrq)76.46
Current ratio (mrq)1.21
Book value per share (mrq)1,832.81

Cash flow statement

Operating cash flow (ttm)1.12T
Levered free cash flow (ttm)1.12T